Previous 10 | Next 10 |
HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today announced that it will issue its financial results for the first quarter ended March 31, 2023 on Monday, May 8, 2023, after the close of the stock ma...
Based on interim efficacy and safety data, Independent Data Monitoring Committee recommends continuation of the trial MADRID, Spain and BOSTON, April 03, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging ...
(NewsDirect) Orion Minerals Ltd (ASX:ORN, JSE:ORN) MD Errol Smart tells Proactive the company is raising $13 million in a two-tranche share placement to sophisticated and professional investors to accelerate the development of its key base metal production hubs in South Africa’s Northe...
2023-03-15 12:36:05 ET Orion Group Holdings, Inc. (ORN) Q4 2022 Earnings Conference Call March 15, 2023, 10:00 AM ET Company Participants Margaret Boyce - IR Travis Boone - CEO Scott Thanisch - CFO Conference Call Participants Julio Romero - Sidoti &a...
In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D Secondary objectives: to assess efficacy MADRID, Spain and BOSTON, March 15, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage bio...
2023-03-13 17:35:55 ET Major earnings expected after the bell on Tuesday include: Skillz ( SKLZ ) SentinelOne ( S ) StoneCo Ltd. ( STNE ) Lennar Corporation ( LEN ) Smartsheet ( SMAR ) For further details see: Notable earnings after Tuesda...
2023-03-13 17:35:10 ET Orion Group ( NYSE: ORN ) is scheduled to announce Q4 earnings results on Tuesday, March 14th, after market close. The consensus EPS Estimate is $0.00 (+100.0% Y/Y) and the consensus Revenue Estimate is $167.72M (+3.4% Y/Y). Over the last 2 years...
A highly selective HDAC-6 inhibitor Rescues motor-neuronal deficiencies in a Charcot-Marie-Tooth model To start IND enabling studies MADRID, Spain and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biop...
2023-03-10 15:54:44 ET Orion Group Holdings ( NYSE: ORN ) has announced multiple contract awards totaling $134M, with the majority of this work to be completed in 2023. Since 2023, the Concrete segment has been awarded $100M across several contracts including $25M for a 22...
Concrete segment secures awards totaling $100 million in core markets of Dallas and Houston Largest diving services contract in Company history HOUSTON, March 10, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction ...
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
Orion Group Holdings Inc. Common Website:
MADRID and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received “Deci...
HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion”, "Company"), a leading specialty construction company, today announced that it will issue its second quarter 2024 financial results after the close of the stock market on Wednesday, July 24, 2...
2024-07-06 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...